Endologix, Inc. (NASDAQ:ELGX)

CAPS Rating: 3 out of 5

The Company develops, manufactures, sells and markets minimally invasive therapies for the treatment of cardiovascular disease.

Recs

0
Player Avatar loangolfer (< 20) Submitted: 12/17/2012 9:09:10 AM : Outperform Start Price: $13.32 ELGX Score: -32.38

Cabot says $45 in '13

Featured Broker Partners


Advertisement